Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Plastic Antibodies Prevent Poisoning in Mouse Model

By LabMedica International staff writers
Posted on 23 Jun 2010
Synthetic plastic nanoparticles have been shown capable of acting like antibodies to selectively attach and remove a toxic substance from the blood of laboratory mice.

Investigators at the University of California, Irvine (USA) in collaboration with colleagues from the University of Shizuoka (Japan) created plastic analogs of an antibody that recognized the poison melittin. More...
Melittin, a peptide of 26 amino acids, is one of the toxic peptides in bee venom.

The artificial antibodies were produced by incubating melittin together with plastic monomers. A chemical reaction was started that allowed the plastic to polymerize around the molecules of melittin, which were then leached out of the matrix. The result was nanoparticles with cavities that matched the structure of melittin.

The investigators reported in the April 26, 2010, online edition of the Journal of the American Chemical Society (JACS) that treating mice that had been injected with a lethal dose of melittin with the synthetic antibodies significantly diminished the mortality and peripheral toxic symptoms of the melittin. In vivo imaging confirmed that the polymer plastic antibodies accelerated clearance of the peptide from the blood and accumulated in the liver.

Commenting on the significance of the results, senior author Dr. Kenneth Shea, professor of medical biochemistry at the University of California, Irvine, said, "This opens the door to serious consideration for these nanoparticles in all applications where antibodies are used.”

Related Links:
University of California, Irvine
University of Shizuoka



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.